Latest News
A New Category of Breast Cancer Means New Possibilities
At the American Society for Clinical Oncology (ASCO) conference earlier this year, a new breast cancer drug received a standing ovation after researchers announced the results of their trial. This drug is Enhertu, and it was recently approved by the FDA to treat people with a certain type of metastatic breast cancer. VBCF doesn’t tend to report on specific drugs for breast cancer treatment because treatment is so individualized – one treatment that works wonders for one person could be ineffective for another. The reason Enhertu warrants some discussion is that it essentially creates a new type of breast cancer that can be a new research focus: HER2-low.
VIDEO: The Microbiome & Breast Cancer
Join VBCF’s Erin Steigleder and Dr. Melanie Rutkowski to learn how the microbiome and breast cancer influence each other. Dr. Rutkowski is an Associate Professor of Microbiology, Immunology, and Cancer Biology at UVA. Learn about the gut microbiome, the breast microbiome (!), and how people can help to keep their beneficial bacteria balanced.
VIDEO: Oral Health & Breast Cancer
VBCF’s Education Manager, Erin Steigleder, chats with two oral health professionals about the importance of looking after your oral health before, during, and after breast cancer treatment. Dr. Sarah Glass is an oral and maxillofacial pathologist and an assistant professor at the VCU School of Dentistry. Dr. Nazy Zahedi is a hospital dentist with VCU.
